3190 results for «727»
3190 results
Challenging TAVI scenarios
14 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!
Challenging CTO cases - Session 2
14 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.
The why and how of performing a successful TAVI case
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, observe a 72-year-old male patient with NYHA class II exertional dyspnoea, CAD status after revascularisation, type II DM, CKD IIIB, recently admitted for decompensated HF and type II NSTEMI, who was referred to the clinic for aortic valve replacement.
Challenging ACS scenarios
14 Dec 2022 – From GulfPCR-GIM 2022
Topics in this GulfPCR-GIM 2022 session include the role of imaging in an unusual case of ACS in a young patient, PCI of an abnormal left coronary artery with AMI, embolisation of a thrombus in a non-culprit vessel during PCI in a late-presenting anterior STEMI, and...
PCI in stable CAD
14 Dec 2022 – From GulfPCR-GIM 2022
Study the two cases presented in this GulfPCR-GIM 2022 session to find out more about the importance of proper monitoring in detecting post-PCI complications and managing complex PCI and coronary stent loss.
What we do
17 Oct 2016
Find out what the key functions and services are of Europa Group, Europa Digital & Publishing and Europa Booking & Services in service of PCR and the cardiovascular community.
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
AsiaPCR 2018: General Terms and conditions of sale